GMPR1 Products

Description

Guanosine monophosphate reductase (EC 1.7.1.7) catalyzes the irreversible NADPH-dependent reductive deamination of guanosine monophosphate (GMP) to inosine monophosphate (IMP). GMPR is able to convert guanosine nucleotides to the pivotal precursor of both guanine (G) and adenine (A) nucleotides. It plays an important role in maintaining the intracellular balance of A and G nucleotides.[supplied by OMIM]

Bioinformatics

Entrez	2766 Human
Uniprot	NM_006877 Human NP_006868 Human NP_006868.3 Human P36959 Human
Product By Gene ID	2766
Alternate Names	EC 1.7.1.7 GMPR1GMP reductase 1 guanine monophosphate reductase Guanosine 5'-monophosphate oxidoreductase 1 Guanosine monophosphate reductase 1 guanosine monophosphate reductase

Diseases related to GMPR1

Discover more about diseases related to GMPR1.

Leukemia
Coronary Artery Disease
Coronary Heart Disease
Ischemia
Ataxia
Schizophrenia
Pathological Dilatation
Leukemia, Myelocytic, Acute
Cardiovascular Diseases
Metabolic Diseases
Malignant Neoplasms
Myeloid Leukemia
Acute Promyelocytic Leukemia
Ataxia, Spinocerebellar
Ventricular Dysfunction
Opca, Menzel Type

Bioinformatics Tool for GMPR1

Discover related pathways, diseases and genes to GMPR1. Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.